Bern, September 7th, 2007 – Pevion Biotech, a Swiss biopharmaceutical company, today announced the appointment of Dr. Klaus Breiner, BB Biotech Ventures, and Dr. Joseph Manko, BZ Bank Aktiengesellschaft, as new members to the company’s board of directors. “We are very pleased to have the additional support of our new investors in our board of directors. The new members not only bring financial expertise, but also considerable experience in building life sciences companies,” commented Peter Klein, CEO of Pevion Biotech.
